• Delivra Health Brands management commentary linked lower revenue for the year ended June 30, 2026, to disrupted Middle East shipments.
• Revenue fell 35.5% to CAD 8.63 million, primarily reflecting weaker US Dream Water sales.
• Gross margin declined to 39% from 51%, reflecting customer and product mix changes, higher warehousing costs and e-commerce expenses.
• Adjusted EBITDA swung to a CAD 1.85 million loss as lower sales outweighed sales and marketing savings.
• Net loss widened to CAD 2.25 million from CAD 1.19 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Delivra Health Brands Inc. published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.